10.80
price down icon5.05%   -0.575
after-market Dopo l'orario di chiusura: 10.90 0.095 +0.88%
loading

Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie

pulisher
11:48 AM

Will breakout in Zevra Therapeutics Inc. lead to full recoveryMarket Growth Report & Fast Momentum Entry Tips - newser.com

11:48 AM
pulisher
09:08 AM

Using economic indicators to assess Zevra Therapeutics Inc. potentialEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com

09:08 AM
pulisher
08:40 AM

Zevra Therapeutics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com

08:40 AM
pulisher
08:28 AM

Zevra Therapeutics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada

08:28 AM
pulisher
04:56 AM

Why Zevra Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Recap & Fast Entry Momentum Alerts - newser.com

04:56 AM
pulisher
01:42 AM

How hedge fund analytics apply to Zevra Therapeutics Inc. stock2025 Market Outlook & Weekly High Conviction Ideas - newser.com

01:42 AM
pulisher
12:06 PM

Analyzing Zevra Therapeutics Inc. with risk reward ratio chartsJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com

12:06 PM
pulisher
Oct 16, 2025

What the charts say about Zevra Therapeutics Inc. today2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Is Zevra Therapeutics Inc. (1GDA) stock a top dividend aristocrat candidate2025 Volatility Report & Expert Curated Trade Setups - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 16, 2025
pulisher
Oct 15, 2025

Should you wait for a breakout in Zevra Therapeutics Inc.July 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Is ZVRA Setting Up For Another Leg Higher? - RTTNews

Oct 15, 2025
pulisher
Oct 15, 2025

Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 2025July 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Is this a good reentry point in Zevra Therapeutics Inc.Gold Moves & Growth Focused Stock Pick Reports - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down Following Insider Selling - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Zevra Therapeutics rises amid takeover speculation - MSN

Oct 13, 2025
pulisher
Oct 12, 2025

What to do if you’re stuck in Zevra Therapeutics Inc.Market Trend Summary & Reliable Momentum Entry Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Insider Selling: Zevra Therapeutics (NASDAQ:ZVRA) CEO Sells 19,500 Shares of Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - 富途牛牛

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics, Inc. $ZVRA Position Cut by Janney Montgomery Scott LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics CEO Neil McFarlane sells $210k in shares By Investing.com - Investing.com Nigeria

Oct 11, 2025
pulisher
Oct 10, 2025

Could Zevra Therapeutics’ (ZVRA) Insider Buying Hint at Greater Management Confidence in Growth Ahead? - Sahm

Oct 10, 2025
pulisher
Oct 10, 2025

Zevra Therapeutics CEO Neil McFarlane sells $210k in shares - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumDip Buying & Stepwise Trade Signal Implementation - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How moving averages guide Zevra Therapeutics Inc. tradingJuly 2025 Summary & Stock Timing and Entry Methods - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Chart overlay techniques for tracking Zevra Therapeutics Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What moving averages say about Zevra Therapeutics Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Yahoo

Oct 10, 2025
pulisher
Oct 09, 2025

Zevra Therapeutics gains amid takeover speculation - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Assessing Zevra Therapeutics (ZVRA) Valuation Following Strong Revenue Growth and Insider Buying - Sahm

Oct 09, 2025
pulisher
Oct 09, 2025

Why global investors buy Zevra Therapeutics Inc. (1GDA) stock2025 Key Highlights & AI Enhanced Trading Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using RSI to spot recovery in Zevra Therapeutics Inc.Earnings Risk Report & Long-Term Investment Growth Plans - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

What drives Zevra Therapeutics Inc stock priceBearish Engulfing Patterns & Breakout Portfolio Performance - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

What drives Zevra Therapeutics Inc 1GDA stock priceEx-Dividend Date Alerts & Affordable Market Growth - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

The Three-year Returns Have Been Decent for Zevra Therapeutics (NASDAQ:ZVRA) Shareholders Despite Underlying Losses Increasing - 富途牛牛

Oct 07, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 06, 2025
pulisher
Oct 06, 2025

38,000-Share Inducement: Zevra Therapeutics Awards Options to Two New Hires, Vesting Over 4 Years - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors - FinancialContent

Oct 06, 2025
pulisher
Oct 06, 2025

Will Zevra Therapeutics Inc. rebound enough to break evenMarket Weekly Review & Weekly High Conviction Ideas - newser.com

Oct 06, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):